The relationship between body mass index, body composition and premenstrual syndrome prevalence in girls
, 2, 3, 2
Abstract
Objectives: Premenstrual Syndrome (PMS) is a cluster of physical and emotional symptoms occurring in the luteal phase of the menstrual cycle. The study aim was to determine the relationship between PMS, and state of nutrition expressed as Body Mass Index (BMI) and body composition in 18-year-old females.
Material and methods: The study was conducted on 476 women divided into two groups i.e. those suffering from PMS (n = 233) and those without symptoms (n = 243). The women were examined during their luteal phase using bioelectrical impedance analysis to determine their body composition. Height and weight were measured using digital medical scales with an electronic height rod. BMI was calculated thus: BMI = body mass (weight) (kg)/height (m2). The subjects were di- vided into two sub-groups: BMI < 25 kg/m2 and BMI ≥ 25 kg/m2. Statistical analysis was carried out using STATISTICA 10 PL software and the Mann-Whitney test.
Results: The women with normal BMI suffered from PMS twice as often as the women with BMI ≥ 25 kg/m2 (68.2% vs. 31.8%). There were significantly higher values for Fat Mass (FM) (%) (p < 0.01) and FM (kg) (p < 0.001) in women without PMS, and significantly higher values for Fat-Free Mass (FFM) (%) (p < 0.001) and Total Body Water (TBW) (%) (p < 0.001) in women with PMS. Higher values were reported for FFM (kg) and TBW (kg) (p < 0.05) in girls with PMS and BMI ≥ 25.
Conclusions: These results show PMS is more frequent in patients with BMI < 25, and less frequent in patients with higher FM (kg) and FM (%). Moreover, significant frequency of PMS was observed in patients with higher FFM and TBW. Such statistical significance was not confirmed in girls with a BMI < 25.
Keywords: premenstrual syndromegynaecologybody composition
References
- Dżygadło B, Łepecka-Klusek C, Pilewski B. Use of bioelectrical impedance analysis in prevention and treatment of overweight and obesity. Probl Hig Epidemiol. 2012; 93(2): 274–280.
- Stanowisko Zespołu Ekspertów Polskiego Towarzystwa Ginekologicznego w sprawie zastosowania leku Mastodynon w ginekologii. Ginekol Pol. 2013; 84: 157–159.
- Green LJ, O’Brien PMS, Panay N, et al. on behalf of the Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome. BJOG. 2017; 124: e73–e105.
- Wan CS, Ward LC, Halim J, et al. Bioelectrical impedance analysis to estimate body composition, and change in adiposity, in overweight and obese adolescents: comparison with dual-energy x-ray absorptiometry. BMC Pediatr. 2014; 14: 249.
- Negi P, Mishra A, Lakhera P. Menstrual abnormalities and their association with lifestyle pattern in adolescent girls of Garhwal, India. J Family Med Prim Care. 2018; 7(4): 804–808.
- Fisher C, Adams J, Frawley J, et al. Is there a role for Western herbal medicine in treating cyclic perimenstrual pain and discomfort? Australian and New Zealand Journal of Obstetrics and Gynaecology. 2018; 59(1): 154–156.
- Arslantaş H, Abacigil F, Çinakli Ş. Relationship between premenstrual syndrome and basic personality traits: a cross-sectional study. Sao Paulo Med J. 2018; 136(4): 339–345.
- Armour M, Ee CC, Hao J, et al. Acupuncture and acupressure for premenstrual syndrome. Cochrane Database Syst Rev. 2018; 8: CD005290.
- Olajossy M, Gerhant A. Zespół napięcia przedmiesiączkowego i przedmiesiączkowe zaburzenia dysforyczne – problem z pogranicza psychiatrii i ginekologii. Curr Probi Psychiatry. 2011; 12(2): 163–170.
- Sadler C, Smith H, Hammond J, et al. Southampton Women's Survey Study Group. Lifestyle factors, hormonal contraception, and premenstrual symptoms: the United Kingdom Southampton Women's Survey. J Womens Health (Larchmt). 2010; 19(3): 391–396.
- Watanabe K, Shirakawa T. Characteristics of Perceived Stress and Salivary Levels of Secretory Immunoglobulin A and Cortisol in Japanese Women With Premenstrual Syndrome. Nurs Midwifery Stud. 2015; 4(2): e24795.
- Pałucka K, Łepecka-Klusek C, Pilewska-Kozak A, et al. Premenstrual syndrome – myth or reality. Journal of Education, Health and Sport. 2016; 6(6): 478–490.
- Masho SW, Adera T, South-Paul J. Obesity as a risk factor for premenstrual syndrome. J Psychosom Obstet Gynaecol. 2005; 26(1): 33–39.
- Bertone-Johnson ER, Hankinson SE, Willett WC, et al. Adiposity and the development of premenstrual syndrome. J Womens Health (Larchmt). 2010; 19(11): 1955–1962.
- Management of Premenstrual Syndrome. BJOG: An International Journal of Obstetrics & Gynaecology. 2016; 124(3): e73–e105.
- Zendehdel M, Elyasi F. Biopsychosocial etiology of premenstrual syndrome: A narrative review. J Family Med Prim Care. 2018; 7(2): 346–356.
- Yonkers KA, O'Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008; 371: 1200–1210.
- Gillings MR. Were there evolutionary advantages to premenstrual syndrome? Evol Appl. 2014; 7(8): 897–904.
- Haghighi ES, Jahromi MK, Daryano Osh F. Relationship between cardiorespiratory fitness, habitual physical activity, body mass index and premenstrual symptoms in collegiate students. J Sports Med Phys Fitness. 2015; 55(6): 663–667.
- Rad M, Sabzevary MT, Dehnavi ZM. Factors associated with premenstrual syndrome in Female High School Students. J Educ Health Promot. 2018; 7: 64.
- Yamada K, Takeda T. Low Proportion of Dietary Plant Protein among Athletes with Premenstrual Syndrome-Related Performance Impairment. Tohoku J Exp Med. 2018; 244(2): 119–122.
- Mohammadi V, Shidfar F, Keshtkar Ag, et al. The relationship of antrhropometric indices with PMS and it’s severity in female students of Tehran University of medical sciences. Raxi J Med Sci. 2013; 20: 87–94.
